TY - JOUR
T1 - The human face of biobank networks for translational research
AU - Meir, Karen
AU - Gaffney, Eoin F.
AU - Simeon-Dubach, Daniel
AU - Ravid, Rivka
AU - Watson, Peter H.
AU - Schacter, Brent
AU - Morente, Manuel M.
AU - Bjugn, Roger
AU - Clark, Brian
AU - De Blasio, Pasquale
AU - Carpenter, Jane
AU - Deschenes, Mylene
AU - Devereux, Lisa
AU - Dhir, Rajiv
AU - Goebell, Peter
AU - Grizzle, William
AU - Hainaut, Pierre
AU - Mes-Masson, Anne Marie
AU - Miranda, Lisa
AU - Parry-Jones, Alison
AU - Riegman, Peter
AU - Casali-Da-Rocha, Jose Claudio
AU - Soares, Fernando
AU - Vaught, Jim
AU - Zeps, Nikolajs
PY - 2011/9/1
Y1 - 2011/9/1
N2 - The biobanking literature frequently addresses donor and societal issues surrounding biobanking, but the biobanker's perspective is rarely highlighted. While not comprehensive, this article offers an overview of the human aspects of biobanking from the viewpoint of biobank personnel-from biobank formation, through the process, and in addressing post-biobanking issues. As every biobank and biobank network may differ, such factors may vary. Before biobanking can commence, the purpose of the biobank network must be defined, and buy-in achieved from many stakeholders. An attitude of trust and sharing is essential, as is good communication. Developing a biobank is time consuming and laborious. Forming a network requires significantly more time due to the need for cross-institutional harmonization of policies, procedures, information technology considerations, and ethics. Circumstances may dictate whether development occurs top-down and/or bottom-up, as well as whether network management may be independent or by personnel from participating biobanks. Funding tends to be a prominent issue for biobanks and networks alike. In particular, networks function optimally with some level of government support, particularly for personnel. Quality biospecimen collection involves meticulously documented coordination with a network of medical and nursing staff. Examining and sampling operative specimens requires timely collaboration between the surgical and pathology teams. "Catch rates" for samples may be difficult to predict and may occur at a frequency less than anticipated due to factors related to the institution, staff, or specimen. These factors may affect specimen quality, and have a downstream effect on competition for specimens for research. Thus, release of samples requires a fair, carefully constructed sample access policy, usually incorporating an incentive for researchers, and an encouragement to form collaborations. Finally, the public and patient groups should aim to understand the benefits of a biobank network, so that patient care is improved through coordinated biobanking activity.
AB - The biobanking literature frequently addresses donor and societal issues surrounding biobanking, but the biobanker's perspective is rarely highlighted. While not comprehensive, this article offers an overview of the human aspects of biobanking from the viewpoint of biobank personnel-from biobank formation, through the process, and in addressing post-biobanking issues. As every biobank and biobank network may differ, such factors may vary. Before biobanking can commence, the purpose of the biobank network must be defined, and buy-in achieved from many stakeholders. An attitude of trust and sharing is essential, as is good communication. Developing a biobank is time consuming and laborious. Forming a network requires significantly more time due to the need for cross-institutional harmonization of policies, procedures, information technology considerations, and ethics. Circumstances may dictate whether development occurs top-down and/or bottom-up, as well as whether network management may be independent or by personnel from participating biobanks. Funding tends to be a prominent issue for biobanks and networks alike. In particular, networks function optimally with some level of government support, particularly for personnel. Quality biospecimen collection involves meticulously documented coordination with a network of medical and nursing staff. Examining and sampling operative specimens requires timely collaboration between the surgical and pathology teams. "Catch rates" for samples may be difficult to predict and may occur at a frequency less than anticipated due to factors related to the institution, staff, or specimen. These factors may affect specimen quality, and have a downstream effect on competition for specimens for research. Thus, release of samples requires a fair, carefully constructed sample access policy, usually incorporating an incentive for researchers, and an encouragement to form collaborations. Finally, the public and patient groups should aim to understand the benefits of a biobank network, so that patient care is improved through coordinated biobanking activity.
UR - http://www.scopus.com/inward/record.url?scp=80053137068&partnerID=8YFLogxK
U2 - https://doi.org/10.1089/bio.2011.0018
DO - https://doi.org/10.1089/bio.2011.0018
M3 - مقالة مرجعية
SN - 1947-5535
VL - 9
SP - 279
EP - 285
JO - Biopreservation and Biobanking
JF - Biopreservation and Biobanking
IS - 3
ER -